Correlation Between Taigen Biopharmaceutica and Sinphar Pharmaceutical
Can any of the company-specific risk be diversified away by investing in both Taigen Biopharmaceutica and Sinphar Pharmaceutical at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Taigen Biopharmaceutica and Sinphar Pharmaceutical into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Taigen Biopharmaceuticals Holdings and Sinphar Pharmaceutical Co, you can compare the effects of market volatilities on Taigen Biopharmaceutica and Sinphar Pharmaceutical and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Taigen Biopharmaceutica with a short position of Sinphar Pharmaceutical. Check out your portfolio center. Please also check ongoing floating volatility patterns of Taigen Biopharmaceutica and Sinphar Pharmaceutical.
Diversification Opportunities for Taigen Biopharmaceutica and Sinphar Pharmaceutical
0.69 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Taigen and Sinphar is 0.69. Overlapping area represents the amount of risk that can be diversified away by holding Taigen Biopharmaceuticals Hold and Sinphar Pharmaceutical Co in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Sinphar Pharmaceutical and Taigen Biopharmaceutica is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Taigen Biopharmaceuticals Holdings are associated (or correlated) with Sinphar Pharmaceutical. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Sinphar Pharmaceutical has no effect on the direction of Taigen Biopharmaceutica i.e., Taigen Biopharmaceutica and Sinphar Pharmaceutical go up and down completely randomly.
Pair Corralation between Taigen Biopharmaceutica and Sinphar Pharmaceutical
Assuming the 90 days trading horizon Taigen Biopharmaceuticals Holdings is expected to under-perform the Sinphar Pharmaceutical. In addition to that, Taigen Biopharmaceutica is 3.61 times more volatile than Sinphar Pharmaceutical Co. It trades about -0.27 of its total potential returns per unit of risk. Sinphar Pharmaceutical Co is currently generating about -0.03 per unit of volatility. If you would invest 3,065 in Sinphar Pharmaceutical Co on September 12, 2024 and sell it today you would lose (15.00) from holding Sinphar Pharmaceutical Co or give up 0.49% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Significant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Taigen Biopharmaceuticals Hold vs. Sinphar Pharmaceutical Co
Performance |
| Timeline |
| Taigen Biopharmaceutica |
| Sinphar Pharmaceutical |
Taigen Biopharmaceutica and Sinphar Pharmaceutical Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Taigen Biopharmaceutica and Sinphar Pharmaceutical
The main advantage of trading using opposite Taigen Biopharmaceutica and Sinphar Pharmaceutical positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Taigen Biopharmaceutica position performs unexpectedly, Sinphar Pharmaceutical can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Sinphar Pharmaceutical will offset losses from the drop in Sinphar Pharmaceutical's long position.The idea behind Taigen Biopharmaceuticals Holdings and Sinphar Pharmaceutical Co pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Optimization module to compute new portfolio that will generate highest expected return given your specified tolerance for risk.
Other Complementary Tools
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data |